SYTL4 downregulates microtubule stability and confers paclitaxel resistance in triple-negative breast cancer

Xiyu Liu, Ding Ma, Li‐Ping Ge, Yun‐Song Yang, Zongchao Gou, Xiao‐En Xu, Zhi‐Ming Shao, Yi‐Zhou Jiang

Theranostics · 2020 · 51 citations · 46 references

DOIFull text

Open access

Concepts

Abstract

SYTL4 is a novel chemoresistant gene in TNBC and its upregulation indicates poor prognosis in taxane-treated TNBC. Further, SYTL4 directly binds microtubules and decreases microtubule stability.

References

46